Contribution of Dynamic Contrast MR Imaging to the Differentiation Between Dural Metastasis and Meningioma

Overview

Journal Neuroradiology

Specialties Neurology
Radiology

Date 2004 Jul 3

PMID 15232661

Citations 32

Authors

S Kremer

S Grand

C Remy

B Pasquier

A L Benabid

S Bracard

J F Le Bas

Affiliations

Soon will be listed here.

Abstract

Purpose: To determine the perfusion-sensitive characteristics of cerebral dural metastases and compare them with the data on meningiomas.

Methods: Twenty-two patients presenting with dural tumor underwent conventional and dynamic susceptibility-contrast MR imaging: breast carcinoma metastases, two patients; colorectal carcinoma metastasis, one patient; lung carcinoma metastasis, one patient; Merkel carcinoma metastasis, one patient; lymphoma, one patient; meningiomas, 16 patients. The imaging characteristics were analyzed using conventional MR imaging. The cerebral blood volume (CBV) maps were obtained for each patient and the relative CBV (rCBV) in different areas was calculated using the ratio between the CBV in the pathological area (CBVp) and in the contralateral white matter (CBVn).

Results: The differentiation between a meningioma and a dural metastasis can be difficult using conventional MR imaging. The rCBVs of lung carcinoma metastasis (1 case: 1.26), lymphoma (1 case: 1.29), breast carcinoma metastasis (2 cases: 1.50,1.56) and rectal carcinoma metastasis (1 case: 3.34) were significantly lower than that of meningiomas (16 cases: mean rCBV = 8.97+/-4.34, range 4-18). Merkel carcinoma metastasis (1 case: 7.56) showed an elevated rCBV, not different from that of meningiomas.

Conclusion: Dural metastases are sometimes indistinguishable from meningiomas using conventional MR imaging. rCBV mapping can provide additional information by demonstrating a low rCBV which may suggest the diagnosis of metastasis.

Citing Articles

Innovation in Non-Invasive Diagnosis and Disease Monitoring for Meningiomas.

Korte B, Mathios D Int J Mol Sci. 2024; 25(8).

PMID: 38673779 PMC: 11050588. DOI: 10.3390/ijms25084195.

Dural tail sign positive tumors: Points to make a differential diagnosis.

Yoon J, Lee K, Na K Radiol Case Rep. 2023; 19(2):773-779.

PMID: 38089139 PMC: 10714320. DOI: 10.1016/j.radcr.2023.10.054.

Meningioma and Other Meningeal Tumors.

Bailo M, Gagliardi F, Boari N, Spina A, Piloni M, Castellano A Adv Exp Med Biol. 2023; 1405:73-97.

PMID: 37452935 DOI: 10.1007/978-3-031-23705-8_3.

Imaging Characteristics of Meningiomas.

Galldiks N, Hattingen E, Langen K, Tonn J Adv Exp Med Biol. 2023; 1416:21-33.

PMID: 37432617 DOI: 10.1007/978-3-031-29750-2_3.

Are there reliable multiparametric MRI criteria for differential diagnosis between intracranial meningiomas and solitary intracranial dural metastases?.

Wu H, Beylerli O, Gareev I, Beilerli A, Ilyasova T, Talybov R Oncol Lett. 2023; 26(2):350.

PMID: 37427340 PMC: 10326821. DOI: 10.3892/ol.2023.13936.

References

Nakau H, Miyazawa T, Tamai S, Tsuchiya K, Shima K, Shirotani T . Pathologic significance of meningeal enhancement ("flare sign") of meningiomas on MRI. Surg Neurol. 1997; 48(6):584-90; discussion 590-1. DOI: 10.1016/s0090-3019(97)00016-5. View

Pathak A, Schmainda K, Ward B, Linderman J, Rebro K, Greene A . MR-derived cerebral blood volume maps: issues regarding histological validation and assessment of tumor angiogenesis. Magn Reson Med. 2001; 46(4):735-47. DOI: 10.1002/mrm.1252. View

Cha S, Knopp E, Johnson G, Wetzel S, Litt A, Zagzag D . Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002; 223(1):11-29. DOI: 10.1148/radiol.2231010594. View

Barbier E, Lamalle L, Decorps M . Methodology of brain perfusion imaging. J Magn Reson Imaging. 2001; 13(4):496-520. DOI: 10.1002/jmri.1073. View

Kremer S, Grand S, Remy C, Esteve F, Lefournier V, Pasquier B . Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol. 2002; 29(2):105-13. View

Johnson M, Powell S, Boyer P, Weil R, Moots P . Dural lesions mimicking meningiomas. Hum Pathol. 2003; 33(12):1211-26. DOI: 10.1053/hupa.2002.129200. View

Rosen B, Belliveau J, Vevea J, Brady T . Perfusion imaging with NMR contrast agents. Magn Reson Med. 1990; 14(2):249-65. DOI: 10.1002/mrm.1910140211. View

Wilms G, Lammens M, Marchal G, Van Calenbergh F, Plets C, Van Fraeyenhoven L . Thickening of dura surrounding meningiomas: MR features. J Comput Assist Tomogr. 1989; 13(5):763-8. DOI: 10.1097/00004728-198909000-00003. View

Quint D, McGillicuddy J . Meningeal metastasis of the cerebellopontine angle demonstrating "dural tail" sign. Can Assoc Radiol J. 1994; 45(1):40-3. View

10.

Goldsher D, Litt A, Pinto R, Bannon K, KRICHEFF I . Dural "tail" associated with meningiomas on Gd-DTPA-enhanced MR images: characteristics, differential diagnostic value, and possible implications for treatment. Radiology. 1990; 176(2):447-50. DOI: 10.1148/radiology.176.2.2367659. View

11.

Tokumaru A, Ouchi T, Eguchi T, Kawamoto S, Kokubo T, Suzuki M . Prominent meningeal enhancement adjacent to meningioma on Gd-DTPA-enhanced MR images: histopathologic correlation. Radiology. 1990; 175(2):431-3. DOI: 10.1148/radiology.175.2.2326470. View

12.

Sheporaitis L, Osborn A, Smirniotopoulos J, Clunie D, Howieson J, DAGOSTINO A . Intracranial meningioma. AJNR Am J Neuroradiol. 1992; 13(1):29-37. PMC: 8331736. View

13.

Hartmann M, Heiland S, Harting I, Tronnier V, Sommer C, Ludwig R . Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett. 2003; 338(2):119-22. DOI: 10.1016/s0304-3940(02)01367-8. View

14.

SIMIONESCU M . Metastatic tumors of the brain: a follow-up study of 195 patients with neurosurgical considerations. J Neurosurg. 1960; 17:361-73. DOI: 10.3171/jns.1960.17.3.0361. View

15.

Buetow M, Buetow P, Smirniotopoulos J . Typical, atypical, and misleading features in meningioma. Radiographics. 1991; 11(6):1087-106. DOI: 10.1148/radiographics.11.6.1749851. View

16.

Provenzale J, Wang G, Brenner T, Petrella J, Sorensen A . Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol. 2002; 178(3):711-6. DOI: 10.2214/ajr.178.3.1780711. View

17.

Rumana C, Hess K, Shi W, Sawaya R . Metastatic brain tumors with dural extension. J Neurosurg. 1998; 89(4):552-8. DOI: 10.3171/jns.1998.89.4.0552. View

18.

Wilms G, Lammens M, Marchal G, Demaerel P, Verplancke J, Van Calenbergh F . Prominent dural enhancement adjacent to nonmeningiomatous malignant lesions on contrast-enhanced MR images. AJNR Am J Neuroradiol. 1991; 12(4):761-4. PMC: 8331606. View

19.

Griebel J, Mayr N, De Vries A, Knopp M, Gneiting T, Kremser C . Assessment of tumor microcirculation: a new role of dynamic contrast MR imaging. J Magn Reson Imaging. 1997; 7(1):111-9. DOI: 10.1002/jmri.1880070115. View

20.

Kremer S, Grand S, Berger F, Hoffmann D, Pasquier B, Remy C . Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology. 2003; 45(1):44-9. DOI: 10.1007/s00234-002-0886-8. View